| Annualized Returns: | 115.87% | Average Win Size: | 3,548.21 |
| Maximum Drawdown: | 16.52% | Average Loss Size: | 2,281.84 |
| Return over Maximum Drawdown: | 7.01 | Win/Loss Size Ratio: | 1.55 |
| Sharpe Ratio (Annualized): | 2.51 | Number of Closed and Open Positions: | 2394 |
| Sortino Ratio (Annualized): | 0.46 | Average Trade Value: | 35,740 USD |
| Number of Wins: | 1256 | Average Closed Trade Duration: | 7.0 days |
| Number of Losses: | 1138 | Last Session Move: | 35,955.00 (1.86%), Baseline move: (-0.44%) |
| Win/Loss Count Ratio: | 1.10 (52% winners) | Win Months(%) | 86.7% |
| Includes 6 open positions with cash holdings of 1,513,653.82 USD Cash holdings are equivalent to 77% of Total Strategy Value (1,966,224.82 USD) at this time. |
|||
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 31.7 | -0.1 | 22.2 | 24.1 | 25.5 | 9.2 | 12.8 | -6.3 | 4.5 | 0.1 | 14.7 | 15.2 | 153.6 |
| 2024 | 17 | 15.5 | 4.5 | -2.1 | 3.2 | 1.5 | 5.5 | 3.5 | 0.7 | 4 | 6.6 | 1.2 | 61.1 |
| 2025 | 1.7 | 2.5 | 0.4 | 3.2 | 0.6 | 6.4 | 4 | 4.5 | 8.8 | 0.6 | 2.8 | -0.1 | 35.4 |
| 2026 | 1.5 | 7 | 1.4 | 9.5 | 14.5 | 11 | -2.7 | 7.9 | -0.7 | 0 | 0 | 0 | 49.4 |
| Symbol | Name | Entry Date | # Shares | Entry Price | Present Price | Move | Max Move | Days Held | Price | Trailing Stop | Profit | Annualized |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera | 2026-08-28 | 100 | 335.28 | 350.78 | 4.62% | 4.62% | 12 | 337.268 (3.9%) | 1,550.00 | 92.4% | |
| BLFS | BioLife Solutions, Inc. | 2026-09-01 | 2100 | 36.98 | 36.39 | -1.59% | 0.24% | 10 | 34.951 (4%) | -1,239.00 | -38.2% | |
| TTRX | Turn Therapeutics Inc. | 2026-09-09 | 4800 | 13.30 | 13.46 | 1.20% | 1.20% | 5 | 12.263 (8.9%) | 768.00 | 57.7% | |
| ABUS | Arbutus Biopharma | 2026-09-09 | 12500 | 5.17 | 5.06 | -2.12% | 0.19% | 5 | 5.020 (0.8%) | -1,375.00 | -102.1% | |
| SION | Sionna Therapeutics, Inc. | 2026-09-15 | 12300 | 7.87 | 6.88 | -12.57% | 4.95% | 1 | 5.354 (22.2%) | -12,177.00 | -3,019.0% | |
| BNGO | Bionano Genomics, Inc. | 2026-09-15 | 74400 | 1.31 | 1.56 | 19.08% | 19.08% | 1 | 1.373 (12%) | 18,600.00 | 4,580.1% | |
| Total Value (USD) of 6 Open Positions: | 440,043.00 | 6,127.00 | 61.7% | |||||||||
| Symbol | Name | # Shares | Buy Date | Buy Price | Sell Date | Sell Price | Max Move | Duration | Price | Profit | ROI |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | 300 | 2026-08-26 | 220.78 | 2026-09-01 | 209.75 | 3.12% | 5 | -3,309.00 | -5% | |
| ARCT | Arcturus Therapeutics | 5100 | 2026-08-27 | 15.74 | 2026-09-01 | 16.23 | 3.11% | 4 | 2,499.00 | 3.1% | |
| RAPP | Rapport Therapeutics, Inc. | 1500 | 2026-08-26 | 50.95 | 2026-09-02 | 48.69 | 3.04% | 6 | -3,390.00 | -4.4% | |
| VIR | ViriBio | 7300 | 2026-08-27 | 11.00 | 2026-09-03 | 11.50 | 5.72% | 6 | 3,650.00 | 4.5% | |
| QNCX | Quince Therapeutics, Inc. | 2800 | 2026-08-31 | 34.04 | 2026-09-03 | 31.76 | 0.00% | 4 | -6,384.00 | -6.7% | |
| CAPR | Capricor Therapeutics, Inc. | 7500 | 2026-09-01 | 10.77 | 2026-09-03 | 9.69 | 0.00% | 3 | -8,100.00 | -10% | |
| INMB | INmune Bio | 32800 | 2026-08-27 | 2.47 | 2026-09-04 | 2.44 | 0.00% | 7 | -984.00 | -1.2% | |
| DWTX | Dogwood Therapeutics, Inc. | 37300 | 2026-08-31 | 2.61 | 2026-09-04 | 2.35 | 3.44% | 5 | -9,698.00 | -10% | |
| SRPT | Sarepta Therapeutics | 3800 | 2026-09-02 | 21.33 | 2026-09-04 | 22.54 | 8.81% | 3 | 4,598.00 | 5.7% | |
| AMGN | Amgen Inc. | 100 | 2026-08-24 | 440.31 | 2026-09-08 | 401.04 | 1.21% | 11 | -3,927.00 | -8.9% | |
| HALO | Halozyme Therapeutics | 700 | 2026-08-25 | 109.33 | 2026-09-08 | 108.66 | 1.30% | 10 | -469.00 | -0.6% | |
| BIIB | Biogen Inc. | 200 | 2026-08-28 | 221.17 | 2026-09-08 | 215.45 | 1.93% | 7 | -1,144.00 | -2.6% | |
| ADIL | Adial Pharmaceuticals | 13100 | 2026-08-24 | 6.19 | 2026-09-11 | 5.57 | 15.02% | 14 | -8,122.00 | -10% | |
| JANX | Janux Therapeutics, Inc. | 4300 | 2026-08-25 | 18.72 | 2026-09-11 | 17.92 | 8.11% | 13 | -3,440.00 | -4.3% | |
| RVMD | Revolution Medicines | 200 | 2026-08-28 | 220.72 | 2026-09-11 | 204.38 | 0.19% | 10 | -3,268.00 | -7.4% | |
| EOLS | Evolus | 11000 | 2026-08-31 | 8.85 | 2026-09-11 | 7.97 | 5.08% | 9 | -9,680.00 | -9.9% | |
| RCKT | Rocket Pharmaceuticals | 25800 | 2026-08-31 | 3.77 | 2026-09-11 | 3.44 | 3.44% | 9 | -8,514.00 | -8.8% | |
| ZYME | Zymeworks | 2700 | 2026-09-01 | 29.32 | 2026-09-11 | 26.43 | 6.88% | 8 | -7,803.00 | -9.9% | |
| CRDL | Cardiol Therapeutics Inc. | 37600 | 2026-09-02 | 2.16 | 2026-09-11 | 2.03 | 2.77% | 7 | -4,888.00 | -6% | |
| SDGR | Schrodinger, Inc. | 3900 | 2026-09-02 | 20.67 | 2026-09-11 | 19.02 | 1.74% | 7 | -6,435.00 | -8% | |
| TARS | Tarsus Pharmaceuticals | 700 | 2026-09-03 | 82.76 | 2026-09-11 | 82.27 | 9.69% | 6 | -343.00 | -0.6% | |
| CABA | Cabaletta Bio | 17900 | 2026-09-03 | 3.63 | 2026-09-11 | 3.27 | 0.00% | 6 | -6,444.00 | -9.9% | |
| LENZ | LENZ Therapeutics, Inc. | 11000 | 2026-09-03 | 5.90 | 2026-09-11 | 5.31 | 1.01% | 6 | -6,490.00 | -10% | |
| RPRX | Royalty Pharma plc | 1000 | 2026-09-04 | 63.55 | 2026-09-11 | 58.95 | 0.64% | 5 | -4,600.00 | -7.2% | |
| VRTX | Vertex Pharmaceuticals Incorporated | 100 | 2026-09-04 | 549.50 | 2026-09-11 | 518.77 | 1.72% | 5 | -3,073.00 | -5.6% | |
| GALT | Galectin Therapeutics Inc. | 14100 | 2026-09-08 | 4.60 | 2026-09-11 | 4.14 | 0.21% | 4 | -6,486.00 | -10% | |
| HOWL | Werewolf Therapeutics, Inc. | 82000 | 2026-08-27 | 0.99 | 2026-09-14 | 0.965 | 0.80% | 12 | -2,050.00 | -2.5% | |
| IOVA | Iovance Biotherapeutics | 7500 | 2026-09-03 | 8.65 | 2026-09-14 | 9.26 | 7.05% | 7 | 4,575.00 | 7.1% | |
| SMMT | Summit Therapeutics | 3700 | 2026-09-08 | 17.43 | 2026-09-14 | 18.42 | 5.67% | 5 | 3,663.00 | 5.7% | |
| COR | Cencora, Inc. | 100 | 2026-09-04 | 333.48 | 2026-09-15 | 324.14 | 1.32% | 7 | -934.00 | -2.8% | |
| TXG | 10X Genomics | 900 | 2026-09-09 | 67.40 | 2026-09-15 | 74.39 | 10.37% | 5 | 6,291.00 | 10.4% | |
| INDP | Indaptus Therapeutics, Inc. | 34800 | 2026-09-14 | 2.80 | 2026-09-15 | 3.64 | 30.00% | 2 | 29,232.00 | 30% |
| Month-To-Date Summary: | |
|---|---|
| MTD Win Trades %: | 21.8% |
| MTD Avg # Entry Trades per Day: | 1.6 |
| MTD Avg # Positions Held: | 16.2 |
| MTD Win/Loss Size Ratio: | 1.62 |
| MTD Avg Trade Duration: | 6.8 |
| MTD Strategy Performance: | -0.83% |
| MTD Baseline (^GSPC) Performance: | -1.30% |
| MTD Strategy Outperformance compared to Baseline: | 0.47% |
| Sold Today: | COR, TXG, INDP |
| Pending Buys: | TMO, ILMN |
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's position, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Investors should consider the investment objectives, risks, and charges and expenses of the above system carefully before investing.
Last Session Date: 2026/09/15